First Trust Advisors LP Kaleido Biosciences, Inc. Transaction History

First Trust Advisors LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$5.36 - $7.99 $295,100 - $439,897	-55,056 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$5.82 - $8.72 $1,507 - $2,258	-259 Reduced 0.47%	55,056 $410,000
Q1 2021 May 14, 2021	BUY	$7.2 - $16.82 $122,479 - $286,125	17,011 Added 44.41%	55,315 $448,000
Q4 2020 Feb 02, 2021	SELL	$5.77 - $11.33 $7,195 - $14,128	-1,247 Reduced 3.15%	38,304 $349,000
Q3 2020 Nov 05, 2020	BUY	$5.09 - $11.07 $145,299 - $316,004	28,546 Added 259.39%	39,551 $438,000
Q2 2020 Jul 22, 2020	BUY	$4.62 - $8.01 $4,245 - $7,361	919 Added 9.11%	11,005 $82,000
Q1 2020 May 06, 2020	SELL	$3.62 - $9.49 $7,073 - $18,543	-1,954 Reduced 16.23%	10,086 $62,000
Q4 2019 Feb 03, 2020	SELL	$5.02 - $8.87 $712 - $1,259	-142 Reduced 1.17%	12,040 $60,000
Q3 2019 Nov 04, 2019	BUY	$6.74 - $11.3 $82,106 - $137,656	12,182 New	12,182 $92,000

2.65K

Ticker KLDO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,622,600
Description
Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the tr...

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

Stay updated on First Trust Advisors LP with notifications on news.